logo
LA County issues ocean water warnings for several beaches

LA County issues ocean water warnings for several beaches

CBS News16-06-2025
The Los Angeles County Department of Public Health is warning of ocean water recreation at several county beaches on Monday, as bacterial levels tested high.
Department officials caution beachgoers against swimming, surfing and playing in the following ocean waters due to bacterial levels exceeding health standards when last tested:
Topanga Canyon Beach, Malibu - 100 yards up and down the coast from the lagoon.
Redondo Beach Pier - 100 yards up and down the coast from the pier.
Ramirez Creek at Paradise Cove - 100 yards up and down the coast from the pier
Santa Monica Pier - 100 yards up and down the coast from the pier.
Castlerock Storm Drain at Topanga County Beach - 100 yards up and down the coast from the storm drain.
Mothers Beach, Marina Del Rey - entire swim area.
Inner Cabrillo Beach, San Pedro - entire swim area.
The Bel Air Bay Club, Will Rogers State Beach - 100 yards up and down coast of the club border fence.
Recorded information on beach conditions is available 24 hours a day on the County's beach hotline at, 1 (800) 525-5662.
For a map of the impacted locations and for more information, visit: publichealth.lacounty.gov/beach.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

West Nile virus-positive mosquitoes found in Los Angeles County for the first time in 2025
West Nile virus-positive mosquitoes found in Los Angeles County for the first time in 2025

CBS News

time2 minutes ago

  • CBS News

West Nile virus-positive mosquitoes found in Los Angeles County for the first time in 2025

West Nile virus-positive mosquitoes were found in Los Angeles County for the first time this year, officials confirmed. The Greater Los Angeles County Vector Control District confirmed the positive samples in a news release on Wednesday. It said as many as six detections were made throughout the county. The mosquitoes were located in: "West Nile virus is a mosquito-borne disease transmitted to people through the bite of an infected Culex mosquito," said Steve Vetrone, GLACVCD Assistant General Manager of Vector Management. "The virus is endemic to Los Angeles County with activity typically increasing during the summer months." The GLACVCD says Culex mosquitoes are most active during dawn and dusk, and the public can reduce the threat of West Nile virus by eliminating standing water and ensuring that pools, spas and ponds are properly maintained. The Centers for Disease Control and Prevention recommends insect repellents that contain DEET, Picaridin, IR3535 or oil of lemon eucalyptus. "While we continue to monitor and treat public spaces, we rely on residents to help reduce mosquito breeding in their properties," Vetrone said. "Dumping out standing water and wearing mosquito repellent are simple but powerful ways to stay protected." West Nile virus, transmitted through mosquito bites, gives symptoms to one in every five infected people. Those symptoms include fever, headache, body aches, nausea or skin rashes, the GLACVCD said.

Jim Cramer Says He 'Was Discouraged to Get a Mixed Update from Abbott Labs'
Jim Cramer Says He 'Was Discouraged to Get a Mixed Update from Abbott Labs'

Yahoo

time30 minutes ago

  • Yahoo

Jim Cramer Says He 'Was Discouraged to Get a Mixed Update from Abbott Labs'

Abbott Laboratories (NYSE:ABT) is one of the stocks that Jim Cramer shed light on. Commenting on the company's recent earnings report results, Cramer said: 'Today, in an otherwise positive market, I was discouraged to get a mixed update from Abbott Labs, medical technology company that we've long owned for the Charitable Trust… I'd say two decades. When Abbott Labs reported this morning, the… results were perfectly solid. Management tightened their full-year earnings guidance rather than raising it while also taking down their organic sales growth forecast and their operating margin outlook. wavebreakmedia/ Abbott (NYSE:ABT) is a healthcare company engaged in the research, development, manufacture, and marketing of a wide range of medical products. While we acknowledge the potential of ABT as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.

Eli Lilly Advances Pipeline and Gene Focus With Verve Acquisition
Eli Lilly Advances Pipeline and Gene Focus With Verve Acquisition

Yahoo

time30 minutes ago

  • Yahoo

Eli Lilly Advances Pipeline and Gene Focus With Verve Acquisition

Eli Lilly and Company (NYSE:LLY) is one of the . Amid carrying on new studies, the company has agreed to acquire Verve Therapeutics. Eli Lilly and Company (NYSE:LLY) is a research-driven pharmaceutical leader headquartered in Indiana. With a 150-year history, the company carries on the business of discovering, developing, manufacturing, and marketing innovative treatments across diseases like diabetes and in fields like oncology, immunology, and neuroscience. Some of the company's notable products, such as Humalog, Trulicity, Mounjaro, and Zepbound, are marketed in over 125 countries. The company is carrying on multiple studies and its latest updates include the Phase 2b clinical study titled 'A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa' and Phase 3 clinical study titled 'A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel Group Phase 3 Efficacy and Safety Study of Lebrikizumab/ LY3650150 in Adults With Chronic Rhinosinusitis With Nasal Polyps on a Background Therapy With Intranasal Corticosteroids.' Along with these studies, the company has a pipeline with potential drugs capable of generating more than $1 billion in annual revenue. Amid these studies, the company has agreed to buy Verve Therapeutics Inc. for up to $1.3 billion. With this acquisition, Eli Lilly and Company (NYSE:LLY) aims to strengthen its positions in gene editing for cardiovascular conditions. With a beta of 0.44 signaling the company's resistance to market conditions, Eli Lilly and Company (NYSE:LLY) has a high anticipated 5-year EPS growth of 41.87%, making the stock a strong contender in our list. While we acknowledge the potential of LLY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Metal Stocks with Insider Buying in 2025 and 10 Energy Stocks with Insider Buying in 2025 Disclosure. None.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store